JPMorgan says own this drug stock. It's one Jim Cramer is itching to buy again

3 days ago 2

The logo of the pharmaceutical company Bristol-Myers Squibb, (BMS) is seen on the facade of the company's Munich headquarters on August 29, 2024 in Munich

(Bavaria). 

Matthias Balk | Picture Alliance | Getty Images

JPMorgan touts Bristol Myers Squibb as a top biopharma pick. Jim Cramer is also quite fond of it.

Read Entire Article
×

🔍 AI Summary

Generating summary...